Insider Holders & Insider Ownership - AVADEL PHARMACEUTICALS PLC (AVDL)

List of insiders holdings for AVADEL PHARMACEUTICALS PLC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 KOTLER KEVIN
Broadfin Capital LLC
Broadfin Healthcare Master Fund Ltd
Director
2020-02-13 17:26:45 1,029,012
0
1,029,012 Form 13G
2 THOMPSON PHILLANDAS T.
See Remarks
2019-03-11 19:16:08 688,671
0
688,671 Form 4
3 Divis Gregory J
Chief Executive Officer
2025-03-07 16:06:44 521,100
10,000
531,100 Form 4
4 KANAN MICHAEL F
See Remarks
2019-03-11 19:10:54 410,538
0
410,538 Form 4
5 DUBOW JORDAN
Chief Medical Officer
2019-04-30 17:51:39 340,000
0
340,000 Form 4
6 Williamson Douglas J
Chief Medical Officer
2022-02-16 16:40:17 275,000
0
275,000 Form 4
7 MONTEITH DAVID
See Remarks
2017-10-11 16:28:39 252,500
0
252,500 Form 4
8 MACKE SCOTT A.
See Remarks
2017-10-11 16:27:33 233,500
0
233,500 Form 4
9 Ende Eric J
Director
2025-01-14 16:22:57 208,900
0
208,900 Form 4
10 DAVIS GREGORY J.
See Remarks
2017-10-11 16:25:22 195,000
0
195,000 Form 4
11 CERUTTI GUILLAUME
See Remarks
2017-06-30 16:17:54 183,440
0
183,440 Form 4
12 MCHUGH THOMAS S
Chief Financial Officer
2025-03-07 16:07:45 172,400
0
172,400 Form 4
13 NAVARRE CHRISTOPHE
See Remarks
2018-07-20 16:08:47 169,417
0
169,417 Form 4
14 VAN ASSCHE BENOIT
See Remarks
2018-07-20 16:11:57 169,417
0
169,417 Form 4
15 FILDES FRANCIS
See Remarks
2018-07-20 16:07:19 150,859
0
150,859 Form 4
16 Vaughn Jason
Sr. VP, Technical Operations
2019-11-14 17:11:10 150,000
0
150,000 Form 4
17 Kim Richard J
Chief Commercial Officer
2024-03-04 06:28:57 147,000
0
147,000 Form 4
18 D'SILVA DHIREN
VP Irish & European Operations
2018-02-07 16:06:26 145,000
0
145,000 Form 4
19 Elrod Marcus W
See Remarks
2017-10-11 16:26:28 125,400
0
125,400 Form 4
20 SULLIVAN STEPHEN G.
See Remarks
2017-10-11 16:29:48 125,000
0
125,000 Form 4
21 Seurer Jerad G.
Gen. Counsel & Corp. Secretary
2025-03-07 16:09:00 107,495
0
107,495 Form 4
22 Thornton Peter J.
Director
2025-01-14 16:24:12 104,055
0
104,055 Form 4
23 McCamish Mark Anthony
Director
2024-08-01 16:32:04 22,000
67,025
89,025 Form 4
24 Glass Geoffrey Michael
Director
2024-12-10 18:13:59 11,000
75,904
86,904 Form 4
25 Hatten Sandra L
See Remarks
2019-12-16 16:21:11 55,765
3,400
59,165 Form 4
26 Palczuk Linda
Director
2025-01-28 16:22:54 0
25,000
25,000 Form 4
27 Amin Naseem
Director
2024-08-01 16:35:13 22,000
0
22,000 Form 4
28 NOHRA GUY P
See Footnotes
2003-10-03 17:46:28 0
6,443
6,443 Form 4
29 GUSKY DAVID P
See Remarks
2019-07-05 16:05:44 0
0
0 Form 4
30 STAPLETON CRAIG R
Director
2019-05-10 16:46:30 0
0
0 Form 4
31 ANDERSON MICHAEL S
See Remarks
2019-01-18 16:09:19 0
0
0 Form 4
32 Flynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Private Design Fund II L.P.
Deerfield Special Situations Fund L.P.
Deerfield Mgmt L.P.
Deerfield Private Design International II L.P.
Breaking Stick Holdings LLC
*Possible member of 10% group
10% Owner
2020-02-13 12:38:41 0
0
0 Form 13G
33 ALTA PARTNERS
ALTA BIOPHARMA PARTNERS LP
ALTA BIOPHARMA MANAGEMENT LLC
ALTA EMBARCADERO BIOPHARMA PARTNERS LLC
ALTA CHASE BIOPHARMA MANAGEMENT LLC
FLAMEL CHASE PARTNERS ALTA BIO LLC
DELEAGE JEAN
GRUENER GARRETT
JANNEY DANIEL
MARDUEL ALIX
10% Owner
2003-10-09 17:18:49 0
0
0 Form 13D